[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100458679":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":42,"centralContacts":46,"locations":51,"responsibleParty":123,"collaborators":34,"id":125,"slug":126,"hasResults":127,"nctId":128,"briefTitle":129,"officialTitle":130,"acronym":131,"eligibilityCriteria":132,"healthyVolunteers":127,"sex":133,"minAge":134,"maxAge":34,"enrollmentInfo":135,"targetDuration":34,"studyType":138,"phases":139,"briefSummary":141,"conditions":142,"keywords":34,"overallStatus":54,"whyStopped":34,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":153},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Oral Tacrolimus + Indomethacin","EXPERIMENTAL","* Tacrolimus Capsule 1-2 hours prior to the endoscopy\n* Rectal Indomethacin immediately after ERCP, in high-risk patients",[13,14],"Drug: Tacrolimus capsule","Drug: Rectal Indomethacin",{"label":16,"type":17,"description":18,"interventionNames":19},"Oral Placebo + Indomethacin","PLACEBO_COMPARATOR","* Placebo Capsule 1-2 hours prior to the endoscopy\n* Rectal Indomethacin immediately after ERCP, in high-risk patients",[20,14],"Drug: Placebo",[22,30,35],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"DRUG","Tacrolimus capsule","Tacrolimus 5 mg PO, 1-2 hours prior to endoscopy",[9],[28,29],"Prograf","Protopic",{"type":23,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"Placebo","Placebo PO, 1-2 hours prior to endoscopy.",[16],null,{"type":23,"name":36,"description":37,"armGroupLabels":38,"otherNames":39},"Rectal Indomethacin","100 mg Rectal Indomethacin immediately after ERCP, in high-risk patients.",[16,9],[40,41],"Indocin","NSAIDS",[43],{"name":44,"affiliation":5,"role":45},"Venkata S. Akshintala, M.D.","PRINCIPAL_INVESTIGATOR",[47],{"name":44,"role":48,"phone":49,"phoneExt":34,"email":50},"CONTACT","+1 (410) 614-6708","vakshin1@jhmi.edu",[52,70,81,96,109],{"facility":53,"status":54,"city":55,"state":56,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"Johns Hopkins Hospital","RECRUITING","Baltimore","Maryland","21287","United States","US",{"type":61,"coordinates":62},"Point",[63,64],-76.61219,39.29038,{"lat":64,"lon":63},[67],{"name":68,"role":48,"phone":69,"phoneExt":34,"email":50},"Venkata S Akshintala, M.D.","410-624-6955",{"facility":71,"status":54,"city":72,"state":73,"zip":74,"country":75,"countryCode":76,"cosmosGeoPoint":34,"geoPoint":34,"contacts":77},"Asian Institute of Gastroenterology","Hyderabad","Andhra Pradesh","500082","India","IN",[78],{"name":79,"role":48,"phone":34,"phoneExt":34,"email":80},"Sundeep Lakhtakia, MD, DM","drsundeeplakhtakia@gmail.com",{"facility":82,"status":83,"city":84,"state":85,"zip":86,"country":75,"countryCode":76,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Apollo Multispecialty Hospitals,","NOT_YET_RECRUITING","Kolkata","West Bengal","700054",{"type":61,"coordinates":88},[89,90],88.36304,22.56263,{"lat":90,"lon":89},[93],{"name":94,"role":48,"phone":34,"phoneExt":34,"email":95},"Mahesh K Goenka, MD, DM","mkgkolkata@gmail.com",{"facility":97,"status":83,"city":98,"state":34,"zip":99,"country":75,"countryCode":76,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"Post Graduate Institute of Medical Education and Research","Chandigarh","160012",{"type":61,"coordinates":101},[102,103],76.7884,30.73629,{"lat":103,"lon":102},[106],{"name":107,"role":48,"phone":34,"phoneExt":34,"email":108},"Saroj K, Sinha","sarojksinha@hotmail.com",{"facility":110,"status":83,"city":111,"state":34,"zip":112,"country":111,"countryCode":113,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Singapore General Hospital","Singapore","169608","SG",{"type":61,"coordinates":115},[116,117],103.85007,1.28967,{"lat":117,"lon":116},[120],{"name":121,"role":48,"phone":34,"phoneExt":34,"email":122},"Clement CH Wu","clement.wu.c.h@singhealth.com.sg",{"type":124,"investigatorFullName":34,"investigatorTitle":34,"investigatorAffiliation":34,"oldNameTitle":34,"oldOrganization":34},"SPONSOR","100458679","phase-3-rectal-indomethacin-and-oral-tacrolimus-versus-combination-to-prevent-post-ercp-pancreatitis-100458679",false,"NCT05252754","Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis","A Randomized Trial Comparing Rectal Indomethacin Alone Versus a Combination of Rectal Indomethacin and Oral Tacrolimus for Post-ERCP Pancreatitis Prophylaxis","INTRO","Inclusion Criteria:\n\n* Any patient who is undergoing endoscopic retrograde cholangiopancreatography (ERCP) at any of the participating centers, is at least 18 years old and provides informed consent can be included in the study.\n\nExclusion Criteria:\n\n* Unwillingness or inability to consent for the study.\n* Pregnancy\n* Breastfeeding mother\n* Chronic calcific pancreatitis\n* ERCP for biliary stent exchange or removal\n* ERCP in a patient with prior biliary sphincterotomy, but without anticipated pancreatogram.\n* Biliary intervention in a patient with pancreas divisum.\n* Standard contraindications to tacrolimus or NSAID use.\n* Current tacrolimus or immune modulator use.\n* Chronic kidney disease with glomerular filtration rate (GFR) \\\u003C 30 or acute kidney injury.\n* Absence of rectum.\n* Acute pancreatitis within 30 days of ERCP.\n* Pancreatic head malignancy.\n* Sphincter of Oddi dysfunction (Type 3).","ALL","18 Years",{"count":136,"type":137},4874,"ESTIMATED","INTERVENTIONAL",[140],"PHASE3","This research is being done to see if using oral tacrolimus before endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).",[143],"Post-ERCP Acute Pancreatitis","2025-12-05",{"date":146,"type":147},"2025-12-09","ACTUAL",{"date":149,"type":147},"2023-01-18",{"date":151,"type":137},"2026-12",{"name":5,"class":6},5]